echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > In the past 30 days, the deputy general managers of 6 pharmaceutical companies such as Silitai and Harbin Pharmaceutical have changed!

    In the past 30 days, the deputy general managers of 6 pharmaceutical companies such as Silitai and Harbin Pharmaceutical have changed!

    • Last Update: 2022-09-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In the past 30 days, there are still a number of pharmaceutical companies in Shanghai and Shenzhen that have undergone personnel changes, including many deputy general manager positions
    .
    According to the author's incomplete statistics, there are at least 6 changes in the deputy general managers of pharmaceutical companies, involving pharmaceutical companies
    such as Silitai and Harbin Pharmaceutical.
     

    Among them, there are many
    pharmaceutical companies that have resigned from the deputy general manager.
     

    For example, on August 11, Yihua Health announced that the company's board of directors recently received a written resignation report
    submitted by Mr.
    Yan Xiaojia, deputy general manager and secretary of the board of directors.
    Mr.
    Yan Xiaojia applied to resign as deputy general manager, secretary of the board of directors and related positions of subsidiaries of the company due to personal reasons
    .
    After his resignation, Mr.
    Yan Xiaojia will not hold other positions in the
    company.
    As at the date of this announcement, Mr.
    Yan Xiaojia does not hold shares in the
    Company.
     

    On August 10, Harbin Pharmaceutical Group announced that the board of directors of the company recently received a written resignation report
    submitted by Mr.
    Xiao Qiang, deputy general manager of the company.
    Due to personal reasons, Mr.
    Xiao Qiang resigned as the deputy general manager of the company and will no longer hold any other position in the
    company after his resignation.
     

    On August 3, Si Litai announced that the company recently received a written resignation report from Mr.
    Fang Qinhu, deputy general manager of the company, who applied for resignation as deputy general manager of the company due to personal reasons, and mr.
    Qinhu no longer held any position in
    the company after resigning.
    According to the relevant regulations, the resignation report of Mr.
    Fang Qinhu shall take effect
    from the date of delivery to the Board of Directors of the Company.
    Mr.
    Fang Qinhu's resignation will not affect the normal production and operation of the
    company.

     

    From the perspective of the reasons for the resignation of the deputy general manager of the above-mentioned pharmaceutical companies, it is mainly based on personal reasons, and the analysis believes that the current resignation of senior executives is related to
    the pressure on all aspects of the pharmaceutical industry.

     

    Of course, there are resignations, and there are also some new deputy general managers of
    pharmaceutical companies.

     

    For example, on August 30, Sichuang Medical Hui announced that after the nomination of the company's general manager and the review of the nomination committee of the fifth board of directors of the company, it was agreed to appoint Mr.
    Peng Jun as the deputy general manager of the company, and the term of office was from the date of deliberation and approval of the board of directors to the date of expiration of the term of the fifth board of directors
    .
    Mr.
    Peng Jun has successively served as an associate researcher of Hangzhou Normal University, an assistant to the general manager of Hangzhou Yinjiang Intelligent Equipment Co.
    , Ltd.
    , and a director and executive director of many companies
    .

     

    On August 26, Huiyu Pharmaceutical issued an announcement on the resignation of the secretary of the board of directors of the company and the appointment of deputy general manager and the appointment of him to act as the secretary of the board of directors, which showed that Ms.
    Liu Jingmo, the secretary of the board of directors of the company, resigned
    for personal reasons.
    On the same day, the Board of Directors of the Company agreed to appoint Ms.
    Marina as the Deputy General Manager of the Company for a term of office from the date of deliberation and approval of the Current Board of Directors to the date of expiration of the term of office of the current Board of Directors
    .
    At the same time, the Board of Directors agreed to appoint Ms.
    Marina to act as Secretary of the Board of Directors of the
    Company.
    According to the information, Ms.
    Malina once served as the manager of the general manager office of Beijing Zhaoyan New Drug Research Center, the director of the general manager office/securities department of Shu Taishen (Beijing), the representative of securities affairs, and the directors
    , vice presidents and secretaries of the board of directors.

     

    On August 20, Xinhua Medical announced that according to the relevant regulations, the company's meeting deliberated and passed the "Proposal on the Appointment of the Deputy General Manager of the Company", and after the nomination of the general manager of the company, Mr.
    Zhu Qingguo and Mr.
    Wang Jianjian were appointed as the deputy general managers of the
    company.
    Among them, Zhu Qingguo successively served as the chief engineer and deputy director of the company's pharmaceutical equipment factory; Deputy General Manager of Pharmaceutical Equipment Division; Deputy General Manager and General Manager of Pharmaceutical Technology Group; Head of Heze Branch of
    Xinhua Medical.
    Wang Jianqiang successively served as the chief engineer of the company's infection control equipment plant; Chief Engineer, Deputy General Manager and General Manager
    of Infection Control Products Division.

     

    The industry said that the deputy general manager generally plays an important role in pharmaceutical companies, and behind the frequent changes in the deputy general managers of major pharmaceutical companies, it can be seen that the changes in the pharmaceutical market continue
    .

     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.